The Association of European Manufacturers of Autogenous Vaccines and Sera, EMAV, has published a comprehensive Manual of Autogenous Vaccines. This unique publication was prepared by well recognised scientists from veterinary universities in Europe, experienced veterinary experts and specialists from the circle of EMAV member companies.
The Manual covers the importance of Autogenous Vaccines (AV) for a modern vaccine portfolio and general aspects of their use including basic epidemiological aspects and a discussion of newly introduced terms like epidemiological unit and epidemiological link. Authors discuss specific keeping, management and production conditions influencing the use of AV for food producing animal species, small animals, Zoo animals and captive wildlife extensively and present pathogen-related examples for the production and application of AV in the veterinary practice today.
The report on the common IABS - EMAV meeting about Autogenous vaccines, held on 14-16 September in Munich, explored the expectations and views of different stakeholders regarding the implementation of the new veterinary medicines Regulation (Reg. (EU) 2019/6) in respect to inactivated Autogenous vaccines in non-notifiable diseases.
The scientific note “Autogenous vaccines: Quality of production and movement in a common market” by Kornelia Grein, Carmen Jungbaeck and Vaughn Kubiak, published in BIOLOGICALS, is accessible at Elsevier and ScienceDirect at https://authors.elsevier.com/sd/article/S1045-1056(22)00003-3.
BIOLOGICALS, the journal of the International Alliance for Biological Standardization (ISSN: 1045-1056) provides a modern and multidisciplinary international forum for news, debate, and original research on all aspects of biologicals used in human and veterinary medicine.